Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease.


A crossover pilot study was undertaken to compare the acceptability of controlled release salbutamol tablets (8 mg twice daily) with a sustained release theophylline preparation (400-800 mg given once each night) in patients with reversible obstructive airways disease. A 2-week run-in period was used to titrate the theophylline dosage. Patients were then… (More)


  • Presentations referencing similar topics